Skip to the record

Home / The Peptara Labs Record

One supplier, on the record

Peptara Labs: What Is Published for the CJC-1295 with Ipamorelin Product

This is the supplier this site earns a commission on, set out in full and read by the same rules as every row in the table.

The row group in the flagship table names one supplier this site links. This page is that row expanded: what Peptara Labs publishes for this product, and, just as plainly, where it publishes nothing. It quotes what the supplier states and never claims to have opened a file it did not open.

Answers: peptara labs cjc 1295 ipamorelin certificate Results recorded 2026-09-01

What the catalog names

Peptara Labs lists a CJC-1295 with Ipamorelin product inside a catalog of 16 research-grade items. The catalog name joins the two compounds with the word with, not with a symbol, so the pair is stated rather than punctuated. The live page describes the platform as a newer one, and this site repeats that word and does not upgrade it to established or long-standing.

You can read the catalog on the supplier's products page. This site publishes no vial size, no amount and no price for it, because a satellite links the page instead of restating an offer.

The certificate for this product

Fourteen of the sixteen items have a published certificate. The two shown as pending are Epithalon and Glutathione, so this product is not one of the two pending items, and a certificate for it is published rather than promised. Across the catalog, fourteen certificate documents and four second-laboratory reports are published and linked from the certificates page.

This site describes that set as published and linked, and no more. It did not download or open this product's certificate this run, so it makes no claim about having read it. It links the page and lets a reader open the document for themselves at the supplier's certificates page.

The panel and the laboratory

Each published certificate confirms identity by HPLC retention-time matching and by LC-MS, and reports chromatographic purity by HPLC against a not-less-than 95.0 percent release criterion. The panel also covers net peptide content, sterility, bacterial endotoxin, heavy metals and a fentanyl immunoassay screen. The heavy metal panel covers arsenic, cadmium, chromium, mercury and lead, all returned Not Detected on the published batches.

Every batch is tested by Titreon Analytical, a third-party laboratory whose quality system is aligned to ISO/IEC 17025:2017, not itself accredited. Across the current published catalog, measured purity runs 98.6 to 99.6 percent, summarised on the homepage as 99% average purity. That is a catalog-wide figure, and this site never restates it as a number for this pair. A certificate carries a batch identifier and a date of test, and this site does not reproduce the net-content figure that also appears there.

Where it publishes nothing

The honest half of a record is where it goes quiet. A second laboratory supplies a separate bacterial endotoxin report on four other batches: Retatrutide, Tirzepatide, BPC-157 and GHK-Cu. Those four second-laboratory reports do not cover this product's batch, and this page states that rather than letting a reader assume the coverage carries over.

The supplier states that a second-laboratory report carries a unique verification key that can be checked at janoshik.com/verify. This site did not test that key. That host was not reachable to this site's own check, so the verify step is reported only as a statement the supplier makes, and it is named in text rather than linked.

Unlabeled vials and the route back

Vials ship unlabeled by design, and no lot is printed on the vial. The published route back to a certificate is to message support with the order number, which is the thread that stands in for a printed label. This site records the practice and the route exactly as stated, and reads nothing off a vial that carries nothing to read. The full account is at the unlabeled-vial practice in full.

The guarantee

The supplier publishes a sixty-day money back guarantee, counted from delivery: send a vial to an outside laboratory, and if it does not test as stated on its certificate, or the order was not handled correctly, the order is refunded in full. It is stated as a quality guarantee and never as a health-outcome guarantee. Sixty days is the figure this site uses, set out on the supplier's trust page.

Entity and partner registrations

Peptara Labs LLC is a registered United States company in Wyoming, Filing ID 2026-002031026, business address 30 N Gould St Ste 66115, Sheridan, WY 82801. It operates as a strategic partner of Sheer Skincare International Corporation, registered in the Philippines, which holds a Philippine FDA License to Operate as a cosmetic trader, LTO-3000014576518, and a Philippine SEC certificate of incorporation, Reg. No. 2024120182028-11.

Those registrations are held by the partner and not by Peptara Labs, neither is an approval of any product, and the License to Operate is a facility license for a cosmetic trader that does not mean any peptide sold has been evaluated by the FDA for safety or effectiveness. This site keeps that qualifier attached to the registrations, because the registrations without it read as an approval that they are not.

The published review figures

The supplier publishes two review figures: 4.96 stars across more than 400 verified order reviews, each tied to an individual order, and 5.0 stars across 39 reviews on a public Google Business Profile. The page states the reviews are not written by the company and that no incentive is offered in exchange for one, and it carries the stamp last updated July 15, 2026.

Those are that party's published figures, quoted as its own. This site does not round them, does not average the two together, and never re-emits them as its own rating in copy or in structured data. Read them at the supplier's reviews page. The supplier also describes itself as a supplier of research-grade compounds and educational information rather than a medical provider, and states its products are research-grade and are not FDA-approved drugs.